Pharmacological Characteristics of Parenteral IGF-I Administration

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|4|2|123-140

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.4, Iss.2, 2003-04, pp. : 123-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The IGF-I Signaling Pathway

By  

Current Pharmaceutical Design, Vol. 13, Iss. 7, 2007-03 ,pp. : 663-669

Bentham Science Publishers

Access to resources Recommend Favorite

IGF-I Abuse in Sport

By  

Current Drug Abuse Reviews, Vol. 2, Iss. 3, 2009-09 ,pp. : 263-272

Bentham Science Publishers

Access to resources Recommend Favorite

The IGF-I Axis in Thyroid Carcinoma

By  

Current Pharmaceutical Design, Vol. 13, Iss. 7, 2007-03 ,pp. : 729-735

Bentham Science Publishers

Access to resources Recommend Favorite

Depot somatropin: gender affects IGF-I response

By  

Inpharma, Vol. 1, Iss. 1363, 2002-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Physicochemical characteristics and in vitro release from oil-based vehicles of peptidomimetics: parenteral depots for intra-articular administration

By Pedersen Brian Thoning   Østergaard Jesper   Larsen Susan Weng   Cornett Claus   Ankersen Michael   Larsen Claus  

Drug Development and Industrial Pharmacy, Vol. 37, Iss. 1, 2011-01 ,pp. : 62-71

Informa Healthcare

Access to resources Recommend Favorite